| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/08/2007 | CA2624316A1 Tissue disruption treatment and composition for use thereof |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2620127A1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 03/08/2007 | CA2620022A1 Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 03/07/2007 | EP1760082A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as anti-proliferative compounds |
| 03/07/2007 | EP1760079A1 Compounds as cor5 antagonists |
| 03/07/2007 | EP1759710A1 Remedy or preventive for arthritis |
| 03/07/2007 | EP1759700A1 Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders |
| 03/07/2007 | EP1759683A1 Scalp and hair-care composition |
| 03/07/2007 | EP1759597A2 Antiallergic composition |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | EP1758591A1 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology |
| 03/07/2007 | EP1758589A1 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof |
| 03/07/2007 | EP1758588A1 Pharmaceutical composition comprising an ointment and two solubilized active principles |
| 03/07/2007 | EP1758587A1 Use of a pharmaceutical composition comprising calcitriol and clobetasol propionate for the treatment of psoriasis |
| 03/07/2007 | EP1758586A1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase |
| 03/07/2007 | EP1758576A1 Topical and intravaginal microbicidal and antiparasitic compositions comprising quassinoids or quassionid-containing plant extracts |
| 03/07/2007 | EP1758573A1 A pharmaceutical composition and its use |
| 03/07/2007 | EP1758570A1 Composition for treatment of a hydrofluoric acid burn |
| 03/07/2007 | EP1758554A1 Soluble strip for oral or topical adminstration |
| 03/07/2007 | EP1351704B1 Storage stable powder compositions of interleukin-4 receptor |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1028753B2 Delivery of poly (ethylene glycol) -conjugated molecules from degradable hydrogels |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | EP0585242B2 Wound healing |
| 03/07/2007 | CN1925872A Method of preventing ultraviolet ray-induced apoptosis |
| 03/07/2007 | CN1923818A Irreversible inhibitors of tyrosine kinases |
| 03/07/2007 | CN1923816A Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 03/07/2007 | CN1923812A New compounds |
| 03/07/2007 | CN1923266A Leukoderma treating medicine |
| 03/07/2007 | CN1923244A Medicinal composition for treating dermatosis, preparation process and use thereof |
| 03/07/2007 | CN1923240A Oil agent for treating burn and scald |
| 03/07/2007 | CN1923225A Foot soaking medicine for treating itch in the vulva and its preparation method |
| 03/07/2007 | CN1923216A Chinese medicine for treating skin wound |
| 03/07/2007 | CN1923215A Corn plaster |
| 03/07/2007 | CN1923199A Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating moist tetter, dermatitis and psoriasis |
| 03/07/2007 | CN1923169A Water aqua containing clindamycin for treating acne |
| 03/07/2007 | CN1923165A Methods of delivering materials into the skin, and compositions used therein |
| 03/07/2007 | CN1303102C Method for diagnosing and curing alopecia utilizing the Rhor gene of human and rat and the encoding products |
| 03/07/2007 | CN1302815C Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues |
| 03/07/2007 | CN1302813C Transmission system for medicine containing trehalose and hyaluronic acid in use for curing burn and preparing method |
| 03/07/2007 | CN1302803C External use liquid formulation for dermatosis |
| 03/07/2007 | CN1302783C Oral taking preparation for aesthetic health care and preparation method |
| 03/07/2007 | CN1302770C Gel of chlormethine hydrochloride and preparing method |
| 03/07/2007 | CN1302768C Physiologically active agents containing vicinal dithioglycols and use therof in various branches of economy |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186841 Antiinflammation agents |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186756 Steroid derivatives and use thereof as medicaments |
| 03/06/2007 | US7186754 Use of creatine or creatine compounds for skin preservation |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186728 Methylene-4-azasteroids |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186708 Steroidal compounds |
| 03/06/2007 | US7186693 Metalloproteinase inhibitors for wound healing |
| 03/06/2007 | US7186687 for topical administration of peptide copper complex with corticosteroids, coal tar, anthralin, calcipotriene, and tazarotene; dermatology; cosmetics |
| 03/06/2007 | US7186558 Keratinocytes obtained from embryonic stem cells of mammals |
| 03/06/2007 | CA2292895C Cyanoguanidines as cell proliferation inhibitors |
| 03/06/2007 | CA2202228C Novel retinoids |
| 03/01/2007 | WO2007025186A2 Hydrazone agents to treat cutaneous lesions |
| 03/01/2007 | WO2007024680A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 03/01/2007 | WO2007024008A1 Preventive or therapeutic agent for side effect based on cytotoxicity of anticancer therapy containing apoptosis inhibition activity-enhancing protein fnk or nucleic acid encoding the same |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023495A2 Method for production of single- and multi-layer microcapsules |
| 03/01/2007 | WO2007023226A2 Use of a symbiotic for the treatment of atopic dermatitis |
| 03/01/2007 | WO2007022999A1 Polymer conjugates of k-252a and derivatives thereof |
| 03/01/2007 | WO2007022616A2 Hybrid ultrafast laser surgery and growth factor stimulation for ultra-precision surgery with healing |
| 03/01/2007 | WO2006138347A3 Androgen receptor modulator compounds and methods |
| 03/01/2007 | WO2006031922A3 Thyroid hormone analogs for promoting angiogenesis |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049639 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases; reduced side effects; 13-hydroxy-DHA (13-hydroxy-DHA) |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048318 Method for treating psoriasis |
| 03/01/2007 | US20070048311 ANTI-INTERFERON-alpha ANTIBODIES |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | DE202006018519U1 Feuchtigkeitsspendende wasserhaltige Sanddorn-Hautpflegepräparate (Emulsionen) Moisturizing hydrous Sea Buckthorn skincare preparations (emulsions) |
| 03/01/2007 | DE202006018518U1 Wasser- und emulgatorenfreie Sanddorn-Hautpflegepräparate Water and emulgatorenfreie buckthorn skin care products |
| 03/01/2007 | CA2620099A1 Use of a symbiotic for the treatment of atopic dermatitis |
| 03/01/2007 | CA2620032A1 Polymer conjugates of k-252a and derivatives thereof |
| 03/01/2007 | CA2620026A1 Method for production of single- and multi-layer microcapsules |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 03/01/2007 | CA2619365A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 03/01/2007 | CA2609948A1 Vasoactive kit and composition and uses thereof |
| 02/28/2007 | EP1757619A2 Osteoprotegerin in milk |
| 02/28/2007 | EP1757602A1 Vla-4 inhibitor |
| 02/28/2007 | EP1757325A1 Use of botulinum toxin for treating myofascial pain |
| 02/28/2007 | EP1757307A1 Method of regenerating follicles by inhibiting gene capable of inhibting follicle formation or activating gene capable of inducing follicle formation |